Stay updated with breaking news from Nasdaq Cocp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the target of a large decline in short interest in September. As of September 15th, there was short interest totalling 7,100 shares, a decline of 51.4% from the August 31st total of 14,600 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]
Cocrystal Pharma, Inc. (NASDAQ:COCP – Free Report) – Research analysts at HC Wainwright increased their Q3 2023 earnings per share (EPS) estimates for Cocrystal Pharma in a research report issued on Tuesday, August 15th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of ($0.45) for the quarter, up […]
Cocrystal Pharma (NASDAQ:COCP – Get Rating) had its price objective lowered by HC Wainwright from $35.00 to $12.00 in a research note released on Wednesday morning, The Fly reports. HC Wainwright also issued estimates for Cocrystal Pharma’s Q2 2023 earnings at ($0.58) EPS, Q3 2023 earnings at ($0.54) EPS, Q4 2023 earnings at ($0.56) EPS, […]
Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 5,000 shares, a growth of 163.2% from the March 15th total of 1,900 shares. Based on an average daily volume of 84,700 shares, the short-interest ratio is […]
Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) Director Phillip Md Et Al Frost purchased 1,015,229 shares of the stock in a transaction that occurred on Tuesday, April 4th. The stock was acquired at an average cost of $1.97 per share, for a total transaction of $2,000,001.13. Following the completion of the acquisition, the director now […]